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  Background:  Near-infrared spectroscopy (NIRS) continuously measures regional cerebral oxygen saturation (rSO2) noninvasively 
and has been shown to detect even small changes in cerebral oxygen supply-demand balance.  Although widely used, only the effect 
of midazolam on cerebral blood flow has been studied in humans and evidence is lacking about its effect on cerebral metabolic rate.  
We therefore evaluated the effect of midazolam on cerebral oxygen supply-demand balance with NIRS.
  Methods:  Sixty patients undergoing elective coronary artery bypass graft surgery were randomly allocated into either midazolam 
(n = 30) or propofol (n = 30) group.  rSO2 was recorded before induction while patients were breathing room air as baseline, after 
pre-oxygenation with 100% oxygen, after administration of either midazolam or propofol, after completion of administration of sufentanil 
and after tracheal intubation.  Hemodynamic variables including cardiac index and mixed venous oxygen saturation were recorded 
at the same time points.
  Results:  rSO2 and hemodynamic variables were similar between the groups throughout the study period.  After pre-oxygenation, 
rSO2 significantly increased compared to baseline in each group, and did not show any additional increase after administration of 
either midazolam or propofol and sufentanil in both groups.
  Conclusions:  Midazolam preserves cerebral blood flow-metabolism coupling to a similar degree to propofol as assessed by near 
infrared spectroscopy.  (Korean J Anesthesiol 2009; 57: 428∼33)
Key Words:  Cerebral oxygen supply-demand balance, Coronary artery bypass graft surgery, Midazolam, Near-infrared spectroscopy, 
Propofol.
INTRODUCTION
  During induction of general anesthesia, tracheal intubation 
can be far more stimulating than surgical incision requiring 
profound depth of anesthesia often at the expense of hypo-
tension and bradycardia which may result in decreased cardiac 
output and myocardial ischemia [1,2]. Various induction agents 
and techniques have been introduced for patients with coronary 
artery occlusive disease. Among them, combination of either 
midazolam or propofol with sufentanil is being widely used 
with numerous studies reporting their hemodynamic stability [3-5].
  In addition to their safety profile in hemodynamic stability, 
propofol and sufentanil have been well studied in human sub-
jects in terms of cerebral oxygen supply-demand balance with 
both agents decreasing cerebral blood flow and metabolism to 
a similar degree [6-8]. Although widely used, only the effect 
of midazolam on cerebral blood flow has been studied in hu-
mans and evidence is lacking about its effect on cerebral met-
abolic rate [9,10].
  Near-infrared spectroscopy (NIRS) continuously measures re-
gional cerebral oxygen saturation (rSO2) noninvasively and has 
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been shown to detect even small changes in cerebral oxygen 
supply-demand balance elicited by etomidate [11-13]. rSO2 scores 
are also affected by many factors including changes in hemo-
dynamic status, which is more prone to occur during induction 
of general anesthesia in patients with ischemic heart disease 
[14,15]. By far, no comprehensive data exists regarding the in-
fluence of midazolam and hemodynamic changes on rSO2 scores 
during the induction period.
  We, therefore, evaluated the effect of midazolam on cerebral 
oxygen supply-demand balance by continuous monitoring of 
rSO2 in a prospective, randomized and controlled trial with 
concomitant monitoring of hemodynamic variables including 
cardiac index (CI) and mixed venous oxygen saturation (SvO2).
MATERIALS AND METHODS
  This was a prospective, randomized and controlled study. 
After institutional review board approval and with written in-
formed consent, 60 patients scheduled for isolated off-pump 
coronary artery bypass graft surgery (OPCAB) between August 
2006 and March 2007 were studied. Patients undergoing emer-
gent surgery and those with pre-existing neurologic disease, 
lung parenchymal disease, NYHA functional class ≥3, left 
ventricular ejection fraction ＜40%, unstable angina and recent 
myocardial infarction within 1 month were excluded. Patients 
who had significant luminal narrowing of either carotid and/or 
vertebral arteries on preoperative angiography were also excluded. 
All cardiovascular medications except diuretics were continued 
until the day of surgery.
  Patients were randomly allocated into either midazolam (n = 
30) or propofol (n = 30) group by a computerized random-
ization table. Only the anesthesiology nurse, who prepared the 
drugs, was aware of the randomization result and the syringes 
containing the drugs were wrapped with non-transparent black 
vinyl for blinding.
  Upon arrival at the operating room, standard monitoring de-
vices were applied and a radial artery catheter was inserted 
under local anaesthesia for continuous blood pressure 
monitoring. Also, a pulmonary artery catheter (Swan-Ganz 
CCOmboⓇ CCO/SvO2, Edwards Lifesciences LLC, USA) was 
inserted via the right internal jugular vein under local anes-
thesia for continuous measurement of CI and SvO2. Bispectral 
index (A-2000TM, Aspect Medical Systems, Natwick, MA, USA) 
and rSO2 (INVOS 5100TM, Somanetics, Troy, MI, USA) were 
continuously monitored with both sensors applied to the fore-
head of the patients.
  Hemodynamic variables, BIS and rSO2 scores were recorded 
at the following time points; before induction while patients 
were breathing room air (T1, baseline), after pre-oxygenation 
with 100% oxygen for at least 3 min through tight-fitting an-
esthetic mask (T2), 3 min after administration of either mid-
azolam 0.05 mg/kg or propofol 1 mg/kg according to random-
ization (T3), 3 min after completion of administration of su-
fentanil 1.5−2 μg/kg (T4) and 5 min after tracheal intubation 
(T5). The chosen doses of the drugs are conventionally used 
doses for induction of anesthesia in Korean patients undergoing 
OPCAB which provide sufficient depth of anesthesia without 
recall.
  Arterial blood gas analyses were performed at T1 and T5. 
Venous blood gas analysis was performed only at T1 for cali-
bration of SvO2. End-tidal carbon dioxide tension (Et-CO2) was 
monitored with side-stream capnography of the anesthesia ma-
chine (Primus, Dräger, Lübeck, Germany) and also recorded at 
T2, T3, T4 and T5. During T3 and T4, the patients’ ventilation 
were manually assisted to obtain same level of Et-CO2 as T2 
at a peak airway pressure ＜15 mmHg. Tracheal intubation 
was facilitated with rocuronium bromide 0.9 mg/kg which was 
administered either after the patients no longer obeyed to verbal 
command to open their eyes or BIS score was below 60. 
After tracheal intubation, the lungs were ventilated with a tidal 
volume of 8−10 ml/kg, at a rate of 8−12 breaths/min in 
100% oxygen to obtain the same level of Et-CO2 as T2 with-
out positive end-expiratory pressure during the study period.
  During induction of anesthesia, 6−8 ml/kg of isotonic crys-
talloid solution was infused in all patients. Phenylephrine 100 μg 
was administered when the mean systemic arterial pressure (MAP) 
was decreased to below 60 mm Hg. Hemodynamic variables 
and rSO2 scores before and after phenylephrine administration 
were also recorded.
  Statistical analyses were performed using SPSS 12.0 (SPSS 
Inc., Chicago, IL, USA). Data were assessed for normal dis-
tribution of variance with Kolmogorov-Smirnov test. All data 
are expressed as number of patients or mean ± SD. We de-
termined that 22 patients would be required in each group 
with 90% power to detect a 10% difference in rSO2 score be-
tween the groups with a SD of 10% and alpha level of 0.05. 
Data between the groups were compared using Chi-square test, 
Fisher's exact test or independent t-test as appropriate. Changes 
between time points within the groups were compared using 
repeated-measures of ANOVA. A P value of less than 0.05 
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Table 1. Patients’ Characteristics
Midazolam 
(n = 30)
Propofol 
(n = 30)
P value
Age (yr)
Gender (M/F)
Body surface area (m2)
Diabetes (n)
Hypertension (n)
Preoperative medication (n)
  Nitrate
  β-blockers
  Calcium channel blockers
  RAS antagonists
LVEF (%)
65 ± 6
20/10
1.7 ± 0.2
14
18
 2
21
13
 8
59 ± 12
63 ± 9
20/10
1.7 ± 0.2
 9
20
 7
20
20
 7
63 ± 11
0.407
1.000
0.772
0.117
0.762
0.144
0.779
0.194
0.769
0.253
Values are mean ± SD or number of patients. No significant 
differences were observed between the groups. RAS: renin-angio-
tensin system, LVEF: left ventricular ejection fraction. 
Table 2. Changes in Bispectral Index (BIS), Regional Cerebral Oxygen Saturation (rSO2), Arterial Oxygen Saturation (SaO2) and End Tidal 
Carbon Dioxide Tension (Et-CO2)
Group T1 T2 T3 T4 T5
BIS
rSO2L (%)
rSO2R (%)
SaO2 (%)
Et-CO2 (mmHg)
Midazolam
Propofol
Midazolam
Propofol
Midazolam
Propofol
Midazolam
Propofol
Midazolam
Propofol
 95 ± 3*
93 ± 4
65 ± 9
66 ± 7
 64 ± 10
66 ± 7
95.9 ± 2.2
95.8 ± 3.4
94 ± 5*
91 ± 6
72 ± 9†
74 ± 8†
71 ± 9†
74 ± 8†
99.7 ± 0.5†
99.7 ± 0.9†
35 ± 4
35 ± 2
   71 ± 10*,†,‡
  58 ± 15†,‡
74 ± 9†
74 ± 8†
73 ± 9†
74 ± 8†
99.8 ± 0.4†
99.9 ± 0.2†
35 ± 5
35 ± 3
  41 ± 6*,†,‡
 45 ± 7†,‡
72 ± 9†
73 ± 9†
71 ± 9†
 73 ± 10†
99.0 ± 0.4†
99.9 ± 0.2†
34 ± 4
34 ± 3
 41 ± 9†
 43 ± 8†
70 ± 9
70 ± 9
68 ± 9
 70 ± 10
 99.5 ± 0.3†
 99.9 ± 0.3†
34 ± 3
34 ± 3
Values are mean ± SD. L: left, R: right, T1: while patients were breathing room air, T2: 3 min after breathing 100% oxygen through 
tight-fitting anesthetic mask, T3: 5 min after administration of either midazolam 0.05 mg/kg or propofol mg/kg, T4: 3 min after completion 
of administration of sufentanil 1.5−2 mg/kg, T5: 5 min after tracheal intubation. *P ＜ 0.05 compared to propofol group, †P ＜ 0.05 vs 
T1, ‡P ＜ 0.05 compared to value of the previous time point.
was considered as statistically significant.
RESULTS
  Data from 60 patients were analyzed. Patients’ characteristics 
were similar between the two groups (Table 1).
  Changes in BIS and rSO2 scores are shown in Table 2. BIS 
scores were significantly higher at T1, T2, T3 and lower at 
T4 in the midazolam group. At T3, after administration of ei-
ther midazolam or propofol, 27 patients in the midazolam 
group and all patients in the propofol group did not respond 
to verbal command to open their eyes, despite BIS scores be-
ing over 60 in 25 and 14 patients in each group, respectively. 
BIS scores in all patients fell below 60 after administration of 
sufentanil at T4 and none of the patient had recall afterwards. 
The rSO2 scores were similar between the groups throughout 
the study period. After pre-oxygenation at T2, rSO2 scores 
were significantly increased compared to baseline scores at T1 
in each group, and did not show any additional increase after 
administration of either midazolam or propofol and sufentanil 
in both groups. The rSO2 scores at T5, 5 min after tracheal 
intubation bore no statistical significance compared to values of 
all other time points including baseline value in both groups.
  Arterial oxygen saturations measured by pulse oximetry were 
similar between the groups and were significantly increased af-
ter pre-oxygenation and remained constant thereafter throughout 
the study period in each group (Table 2). Arterial oxygen ten-
sions were 89 ± 16 mmHg, 391 ± 74 mmHg in the mid-
azolam group and 86 ± 11 mmHg, 412 ± 70 mmHg in the 
propofol group at T1 and T5, respectively with both groups 
showing significant increase compared to baseline values at T1 
of each group. Hematocrit concentrations were 37 ± 4%, 33 ± 
4% in the midazolam group and 38 ± 4%, 35 ± 4% in the 
propofol group at T1 and T5, respectively with both groups 
showing significant decrease compared to baseline values at T1 
of each group without any significant difference between the 
groups. Arterial carbon dioxide tensions were 38 ± 2 mmHg, 
38 ± 4 mmHg in the midazolam group and 39 ± 3 mmHg, 
38 ± 3 mmHg in the propofol group at T1 and T5, re-
spectively without any significant differences between the 
groups. pH at T1 and T5 were all 7.45 ± 0.03 in both 
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Table 4. Changes in Regional Cerebral Oxygen Saturation (rSO2) 
Scores and Hemodynamic Variables of the 23 Patients Who 
Required Phenylephrine Administration
T3
Before 
phenylephrine
After 
phenylephrine
rSO2L (%)
rSO2R (%)
CI (L/min/m2)
SvO2 (%)
MAP (mmHg)
CVP (mmHg)
76 ± 7
76 ± 7
 3.0 ± 0.6
83 ± 4
 79 ± 11
 7 ± 2
75 ± 7
75 ± 7
3.0 ± 0.6
83 ± 4
56 ± 4*
7 ± 2
75 ± 8
75 ± 8
3.0 ± 0.5
82 ± 6
 74 ± 10†
7 ± 3
Values are mean (SD). T3: 5 min after administration of either 
midazolam 0.05 mg/kg or propofol 1 mg/kg, L: left, R: right, CI: 
cardiac index, SvO2: mixed venous oxygen saturation, MAP: mean 
systemic arterial pressure, CVP: central venous pressure. *P ＜
0.05 vs T3, †P ＜ 0.05 vs before phenylephrine.
Table 3. Changes in Hemodynamic Variables
Group T1 T2 T3 T4 T5
CI (L/min/m2)
SvO2 (%)
MAP (mmHg)
CVP (mmHg)
Midazolam
Propofol
Midazolam
Propofol
Midazolam
Propofol
Midazolam
Propofol
3.0 ± 0.6
3.0 ± 0.5
74 ± 3
76 ± 3
97 ± 14
101 ± 20
7 ± 3
7 ± 3
3.1 ± 0.6
3.0 ± 0.4
82 ± 5*
82 ± 5*
99 ± 14
103 ± 12
6 ± 3
7 ± 3
3.2 ± 0.6
3.0 ± 0.5
85 ± 6*
84 ± 5*
84 ± 15*,†
84 ± 12*,†
7 ± 3
8 ± 2
3.2 ± 0.6
3.1 ± 0.4
82 ± 6*
83 ± 6*
  70 ± 11*,†
 70 ± 9*,†
7 ± 3
7 ± 2
3.1 ± 0.6
3.2 ± 0.6
82 ± 9*
82 ± 6*
 75 ± 16*
 79 ± 11*
7 ± 3
7 ± 2
Values are mean ± SD. T1: while patients were breathing room air, T2: 3 min after breathing 100% oxygen through tight-fitting anesthetic 
mask, T3: 5 min after administration of either midazolam 0.05 mg/kg or propofol mg/kg, T4: 3 min after completion of administration of 
sufentanil 1.5−2 mg/kg, T5: 5 min after tracheal intubation, CI: cardiac index, SvO2: mixed venous oxygen saturation, MAP: mean sys-
temic arterial pressure, CVP: central venous pressure. *P ＜ 0.05 vs T1, †P＜ 0.05 compared to value of the previous time point.
groups. Et-CO2 from T2 to T5 were similar between the 
groups with no significant differences between each time points 
within group (Table 2).
  Changes in hemodynamic variables are shown in Table 3. 
CI and central venous pressure (CVP) were similar between 
the groups throughout the study period with no significant dif-
ferences between each time points within group. SvO2 and 
MAP were also similar between the groups throughout the 
study period. SvO2 was increased in both groups at T2, T3, 
T4 and T5 compared to baseline values of each group. MAP 
was decreased in both groups at T3, T4 and T5 compared to 
baseline values of each group.
  Phenylephrine bolus to maintain MAP at predefined level 
was administered to 12 and 11 patients in the midazolam and 
propofol group, respectively. All phenylephrine boluses were 
required during or after sufentanil administration. In the 23 pa-
tients, MAP was decreased to a range of 51−60 mmHg and 
significantly increased after phenylephrine administration with 
no significant changes in rSO2 scores (Table 4).
  None of the patients developed ECG changes indicative of 
ischemia during the study period.
DISCUSSION
  In this study, we could observe that midazolam preserves 
cerebral blood flow-metabolism coupling to a similar degree to 
propofol as assessed by NIRS. We could also observe that 
pre-oxygenation alone causes significant increase in rSO2 scores 
and that neither midazolam nor propofol with sufentanil ex-
erted additional increase on rSO2 scores. Transient decrease in 
MAP after sufentanil administration to a range of 51−60 mm 
Hg and subsequent increase with phenylephrine bolus was not 
associated with significant changes in rSO2 scores.
  NIRS noninvasively provides continuous, real-time rSO2 and 
is being increasingly used to detect disturbances in cerebral 
oxygen supply-demand balance, especially in carotid endarter-
ectomy and cardiac surgeries [16,17]. It also has been vali-
dated to detect even small changes in cerebral oxygen sup-
ply-demand balance elicited by administration of etomidate dur-
ing propofol anesthesia [13]. However, to evaluate subtle 
changes in cerebral oxygen supply-demand balance with NIRS 
after administration of a certain drug, other factors affecting 
rSO2 scores such as hemodynamic variables and hematocrit 
concentration should also be assessed and taken into consid-
eration [18-21]. In addition, to avoid confounding effects of 
other anesthetic drugs, which are known to affect cerebral 
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blood flow and/or metabolic rate, the drug which is to be 
evaluated should be administered exclusively. In accordance, 
we have assessed the effects of midazolam on cerebral oxygen 
supply-demand balance by NIRS, with strict control of arterial 
pH by maintaining Et-CO2 constant at its pre-induction value 
and concomitant monitoring of beat to beat hemodynamic 
changes including CI and SvO2. The reason we concomitantly 
monitored SvO2 was that, in case of constant cardiac output, 
any changes in SvO2 may reflect significant changes in the 
oxygen extraction ratio of major organs including the brain, 
which implies changes in oxygen supply-demand balance [22,23]. 
We also administered midazolam exclusively before any other 
anesthetics and used propofol as active control. Propofol al-
ready has been well studied in terms of preserving cerebral 
oxygen supply-demand balance in human subjects by reducing 
both cerebral blood flow and metabolic rate to a similar de-
gree [7,24].
  As our results indicate, arterial oxygen saturation, Et-CO2 
and SvO2 remained constant after pre-oxygenation within each 
group and were also similar between the groups at all time 
points. CI, MAP and CVP were similar between the groups 
throughout the study period. CI and CVP also remained con-
stant in both groups compared to baseline values of each group 
throughout the study period. Although MAP significantly de-
creased in both groups after administration of either midazolam 
or propofol compared to values of T1 and T2 of each group, 
it was well within the range of cerebral autoregulation. 
Midazolam, propofol and sufentanil are all known to preserve 
cerebral autoregulation [7,8,10]. The independence of MAP and 
rSO2 scores, shown when MAP was further decreased to be-
low 60 mmHg after administration of sufentanil and sub-
sequently increased with phenylephrine in the 23 patients, in-
dicate preserved cerebral autoregulation and that MAP is an 
unlikely contributing confounder to the observed rSO2 scores 
[25]. Under the above mentioned conditions, the observed rSO2 
scores assessed by NIRS indicate that midazolam preserves 
cerebral oxygen supply-demand balance to a similar degree as 
propofol.
  Interestingly, Stoneham and Martin have reported reversing 
signs of neurological deficit following cross clamping of car-
otid artery by administration of 100% oxygen probably due to 
increase of the mitochondrial oxygen tension above the critical 
level to restart oxidative phosphorylation in ischemic cerebral 
neurones [26]. In accordance, Baraka et al [27] have reported 
significant increase of rSO2 scores assessed by NIRS after ad-
ministration of 100% oxygen in 6 awake patients. They also 
reported that induction of general anesthesia resulted in further 
increase in rSO2 scores suggesting that monitoring of enhanced 
cerebral oxygen supply-demand balance by NIRS while applying 
high inspired oxygen fraction and induction of general anes-
thesia may decrease the need for shunting of the carotid 
artery. We could also observe similar results with high in-
spired oxygen fraction and rSO2 scores in all 60 patients sup-
porting their suggestion. However, we could not observe addi-
tional significant increase in rSO2 scores after induction of 
general anesthesia. This observation may be in part attributed 
to decrease in hematocrit concentration as a result of hemodi-
lution induced by administration of 6−8 ml/kg of isotonic 
crystalloid solution during the induction period [28].
  The limitations of our study are as follows. First, the rSO2 
probes in this study were attached in the forehead measuring 
rSO2 of the watershed territory corresponding to the junction 
of anterior and middle cerebral artery [11]. Thus, our results 
may not accurately reflect changes of global cerebral oxygen 
supply-demand balance, although we have excluded patients 
with significant luminal narrowing of the carotid and vertebral 
arteries. 
  In conclusion, in addition to its’ safety profile regarding he-
modynamic stability, midazolam preserves cerebral oxygen sup-
ply-demand balance to a similar degree to propofol as assessed 
by NIRS during induction of anesthesia. The balance was 
maintained even when MAP was decreased to 51 mmHg, with 
intact cerebral autoregulation observed as independence of rSO2 
scores and changes in MAP. The finding that pre-oxygenation 
alone caused significant increase in rSO2, merits further studies 
to evaluate its potentially beneficial effect on reversing neuro-
logical deficits and the role of NIRS as the monitoring device.
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